29286334|t|A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases.
29286334|a|Although cyanobacterial beta-N-methylamino-l-alanine (BMAA) has been implicated in the development of Alzheimer's Disease (AD), Parkinson's Disease (PD) and Amyotrophic Lateral Sclerosis (ALS), no BMAA animal model has reproduced all the neuropathology typically associated with these neurodegenerative diseases. We present here a neonatal BMAA model that causes beta-amyloid deposition, neurofibrillary tangles of hyper-phosphorylated tau, TDP-43 inclusions, Lewy bodies, microbleeds and microgliosis as well as severe neuronal loss in the hippocampus, striatum, substantia nigra pars compacta, and ventral horn of the spinal cord in rats following a single BMAA exposure. We also report here that BMAA exposure on particularly PND3, but also PND4 and 5, the critical period of neurogenesis in the rodent brain, is substantially more toxic than exposure to BMAA on G14, PND6, 7 and 10 which suggests that BMAA could potentially interfere with neonatal neurogenesis in rats. The observed selective toxicity of BMAA during neurogenesis and, in particular, the observed pattern of neuronal loss observed in BMAA-exposed rats suggest that BMAA elicits its effect by altering dopamine and/or serotonin signaling in rats.
29286334	30	34	BMAA	Chemical	MESH:C001824
29286334	40	43	Rat	Species	10116
29286334	90	116	Neurodegenerative Diseases	Disease	MESH:D019636
29286334	127	141	cyanobacterial	Species	
29286334	142	170	beta-N-methylamino-l-alanine	Chemical	MESH:C001824
29286334	172	176	BMAA	Chemical	MESH:C001824
29286334	220	239	Alzheimer's Disease	Disease	MESH:D000544
29286334	241	243	AD	Disease	MESH:D000544
29286334	246	265	Parkinson's Disease	Disease	MESH:D010300
29286334	267	269	PD	Disease	MESH:D010300
29286334	275	304	Amyotrophic Lateral Sclerosis	Disease	MESH:D000690
29286334	306	309	ALS	Disease	MESH:D000690
29286334	315	319	BMAA	Chemical	MESH:C001824
29286334	403	429	neurodegenerative diseases	Disease	MESH:D019636
29286334	458	462	BMAA	Chemical	MESH:C001824
29286334	506	529	neurofibrillary tangles	Disease	MESH:D055956
29286334	559	565	TDP-43	Gene	298648
29286334	578	589	Lewy bodies	Disease	MESH:D020961
29286334	591	602	microbleeds	Disease	
29286334	607	619	microgliosis	Disease	
29286334	638	651	neuronal loss	Disease	MESH:D009410
29286334	753	757	rats	Species	10116
29286334	777	781	BMAA	Chemical	MESH:C001824
29286334	817	821	BMAA	Chemical	MESH:C001824
29286334	976	980	BMAA	Chemical	MESH:C001824
29286334	1024	1028	BMAA	Chemical	MESH:C001824
29286334	1087	1091	rats	Species	10116
29286334	1116	1124	toxicity	Disease	MESH:D064420
29286334	1128	1132	BMAA	Chemical	MESH:C001824
29286334	1197	1210	neuronal loss	Disease	MESH:D009410
29286334	1223	1227	BMAA	Chemical	MESH:C001824
29286334	1236	1240	rats	Species	10116
29286334	1254	1258	BMAA	Chemical	MESH:C001824
29286334	1290	1298	dopamine	Chemical	MESH:D004298
29286334	1306	1315	serotonin	Chemical	MESH:D012701
29286334	1329	1333	rats	Species	10116
29286334	Positive_Correlation	MESH:C001824	MESH:D055956
29286334	Positive_Correlation	MESH:C001824	MESH:D000690
29286334	Association	MESH:C001824	MESH:D012701
29286334	Positive_Correlation	MESH:C001824	MESH:D020961
29286334	Positive_Correlation	MESH:C001824	MESH:D000544
29286334	Positive_Correlation	MESH:C001824	MESH:D019636
29286334	Association	MESH:C001824	MESH:D004298
29286334	Positive_Correlation	MESH:C001824	MESH:D010300
29286334	Positive_Correlation	MESH:C001824	MESH:D009410

